Benitec Biopharma Ltd (BNTC)

[Blane]

Djs7, at this point, I don't think Benitec is looking for a buyout. If TT-034 works, the value goes above and beyond Hep C and into their other pipelines, as it proves basically that ddrnai works. Additionally, Benitec still has to "finish" the trial for it to be considered complete.

Here is a post from Tonyynot on the Hotcooper board today that may pique your interest.

Thanks, Blane, for the link to the article that includes 'Benitec' as one key participant in the field of firms with a pipeline for drug development under clinical trials for regulatory approval and involving siRNA molecules.
The "late July" investor roadshow in the United States to garner and assess the appetite (and to establish pricing) for Benitec's plans for their IPO on the NASDAQ should be concluded this week. It would not surprise me recent price gains on the ASX continue this week and that the IPO final price range is set at about between 14 and 16 US$. Using that estimates midpoint of $15USD, and with the maximum funds to be raised set at $70 million US$, that would result in 4,666,666 ADSs representing 93,333,333 common shares. Immediately post IPO, my guess would be for the ADSs to be trading at closer to $20 per ADS - representing a common share price in Australian dollars at about $1.40.